ScoreWhy is Jinghua Pharmaceutical Group Co., Ltd. ?
1
Flat results in Mar 26
- OPERATING CASH FLOW(Y) Lowest at CNY 322.91 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.38 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.32 times
2
With ROE of 9.49%, it has a very attractive valuation with a 1.89 Price to Book Value
- Over the past year, while the stock has generated a return of -10.88%, its profits have risen by 13.8% ; the PEG ratio of the company is 1.4
- At the current price, the company has a high dividend yield of 1.4
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -10.88% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jinghua Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jinghua Pharmaceutical Group Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jinghua Pharmaceutical Group Co., Ltd.
16.85%
-0.31
26.62%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.47%
EBIT Growth (5y)
33.16%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.55
Tax Ratio
13.52%
Dividend Payout Ratio
33.42%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.49%
ROE (avg)
7.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
1.75
EV to EBIT
13.41
EV to EBITDA
11.06
EV to Capital Employed
2.34
EV to Sales
2.51
PEG Ratio
1.34
Dividend Yield
1.48%
ROCE (Latest)
17.47%
ROE (Latest)
9.49%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
OPERATING PROFIT(Q)
Highest at CNY 109.98 MM
OPERATING PROFIT MARGIN(Q)
Highest at 29.33 %
PRE-TAX PROFIT(Q)
Highest at CNY 97.42 MM
NET PROFIT(Q)
Highest at CNY 69.51 MM
EPS(Q)
Highest at CNY 0.09
-9What is not working for the Company
INTEREST(HY)
At CNY 0.52 MM has Grown at 11.66%
INTEREST COVERAGE RATIO(Q)
Lowest at 27,556.18
Here's what is working for Jinghua Pharmaceutical Group Co., Ltd.
Operating Profit
Highest at CNY 109.98 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 29.33 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 97.42 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 69.51 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.09
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Here's what is not working for Jinghua Pharmaceutical Group Co., Ltd.
Interest
At CNY 0.52 MM has Grown at 11.66%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 27,556.18
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Footer loading
